enow.com Web Search

Search results

1. Results from the WOW.Com Content Network

2. List of antineoplastic agents - Wikipedia

   en.wikipedia.org/wiki/List_of_antineoplastic_agents

   Tyrosine kinase inhibitor (TKI) with selective activity against RET, VEGFR-2 and EGFR: Medullary thyroid cancer. Diarrhoea, hypertension, QT interval prolongation, depression, electrolyte anomalies, hypothyroidism and GI perforation (uncommon). 2.3 mTOR inhibitors: Everolimus: PO: mTOR inhibitor.

3. Nilotinib - Wikipedia

   en.wikipedia.org/wiki/Nilotinib

   Nilotinib is a Bcr-Abl tyrosine kinase inhibitor and works by interfering with signalling within the cancer cell. [3] [7] Nilotinib was approved for medical use in the United States in 2007. [3] [7] It is on the World Health Organization's List of Essential Medicines. [8] It is approved as a generic medication. [9]

4. Entrectinib - Wikipedia

   en.wikipedia.org/wiki/Entrectinib

   Entrectinib is a selective tyrosine kinase inhibitor with specificity, at low nanomolar concentrations, for all of three Trk proteins (encoded by the NTRK1, 2, and 3 genes, respectively) as well as the ROS1, and ALK receptor tyrosine kinases. [24]

5. The best skin care routine for your 60s, according to ... - AOL

   www.aol.com/lifestyle/best-skin-care-routine-for...

   "In the 60s, the skin tends to become drier, thinner and more delicate due to decreased natural oil production and a decline in collagen and elastin," said Dr. Hannah Kopelman, host of the podcast ...

6. Repotrectinib - Wikipedia

   en.wikipedia.org/wiki/Repotrectinib

   Repotrectinib is indicated for the treatment of adults with locally advanced or metastatic ROS1-positive non-small cell lung cancer. [1] [2]In June 2024, the US Food and Drug Administration (FDA) expanded the indication to include the treatment of people twelve years of age and older with solid tumors that have a neurotrophic tyrosine receptor kinase (NTRK) gene fusion, are locally advanced or ...

7. Tyrosine kinase inhibitor - Wikipedia

   en.wikipedia.org/wiki/Tyrosine_kinase_inhibitor

   A tyrosine kinase inhibitor (TKI) is a pharmaceutical drug that inhibits tyrosine kinases. Tyrosine kinases are enzymes responsible for the activation of many proteins by signal transduction cascades. The proteins are activated by adding a phosphate group to the protein (phosphorylation), a step that TKIs inhibit. TKIs are typically used as ...